KellBenx

About:

Kellbenx focuses on the development of non-invasive prenatal diagnosis for specific genetic and other heritable disorders.

Website: http://kellbenx.com

Top Investors: HealthCor Partners

Description:

Kellbenx focuses on the development of non-invasive prenatal diagnosis for specific genetic and other heritable disorders. Its focus is to improve women's healthcare and one of our first tests is in the area of non-invasive prenatal diagnosis (NIPD) for genetic disorders. It was founded in 2010 and headquartered in Massapequa, New York.

Total Funding Amount:

$16.7M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Massapequa, New York, United States

Founded Date:

2010-01-01

Contact Email:

info(AT)kellbenx.com

Founders:

Hassan Bennani, Leonard Kellner

Number of Employees:

1-10

Last Funding Date:

2015-12-07

IPO Status:

Private

Industries: